ZOM Zomedica Corp. Stock Quote

ZOM [AMEX]

Healthcare | Drug Manufacturers - Specialty & Generic | USA

Index	-	P/E	-	EPS (ttm)	-0.08	Insider Own	4.42%	Shs Outstand	550.54M	Perf Week	-21.54%
Market Cap	596.00M	Forward P/E	-	EPS next Y	-0.02	Insider Trans	0.00%	Shs Float	539.13M	Perf Month	526.15%
Income	-15.60M	PEG	-	EPS next Q	0.00	Inst Own	8.50%	Short Float	10.39%	Perf Quarter	1170.24%
Sales	-	P/S	-	EPS this Y	-4.50%	Inst Trans	32.48%	Short Ratio	0.41	Perf Half Y	525.77%
Book/sh	0.08	P/B	12.75	EPS next Y	-	ROA	-63.30%	Target Price	-	Perf Year	230.31%
Cash/sh	0.09	P/C	11.46	EPS next 5Y	-	ROE	-159.30%	52W Range	0.06 - 1.48	Perf YTD	342.32%
Dividend	-	P/FCF	-	EPS past 5Y	-28.50%	ROI	-	52W High	-31.76%	Beta	1.00
Dividend %	-	Quick Ratio	25.60	Sales past 5Y	-	Gross Margin	-	52W Low	1508.28%	ATR	0.15
Employees	28	Current Ratio	25.60	Sales Q/Q	-	Oper. Margin	-	RSI (14)	69.00	Volatility	22.60% 22.70%
Optionable	No	Debt/Eq	0.05	EPS Q/Q	65.60%	Profit Margin	-	Rel Volume	0.50	Prev Close	1.02
Shortable	Yes	LT Debt/Eq	0.03	Earnings	-	Payout	-	Avg Volume	135.31M	Price	1.01
Recom	2.00	SMA20	80.96%	SMA50	227.17%	SMA200	433.47%	Volume	63,169,734	Change	-0.98%

Jan-18-21 06:15AM	Zomedica CEO Issues Shareholder Letter as TRUFORMA Nears Commercialization GlobeNewswire
Jan-15-21 06:23PM	Jeremy Granthams Bubble Forecast Is an Outlier. Is He Right? Barrons.com
Jan-12-21 05:53PM	Penny stock Zomedica jumps 250% after someone paid Netflix star Carole Baskin $299 for a mention Yahoo Finance +39.78%
Jan-04-21 06:10AM	Zomedica Appoints Robert Cohen CEO as Company Nears Commercialization of TRUFORMA GlobeNewswire +51.78%
Dec-15-20 08:53AM	Zomedica to Remain Domiciled in Canada GlobeNewswire
Dec-07-20 06:01AM	Zomedica Completes Internal Launch Team for Upcoming TRUFORMA Commercialization GlobeNewswire
Nov-28-20 08:50PM	Is Zomedica Corp. (ZOM) A Good Stock To Buy Now? Insider Monkey
Nov-18-20 12:38PM	Is Zomedica Stock a Buy Right Now? This Analyst Says Yes TipRanks -12.84%
Nov-13-20 06:00AM	Zomedica Sets March 30, 2021 as Expected Commercialization Date for TRUFORMA GlobeNewswire +18.38%
Nov-12-20 06:30AM	Zomedica Announces Third Quarter 2020 Financial Results GlobeNewswire
Oct-26-20 09:25AM	Zomedica Announces Letter From Robert Cohen, Interim CEO, Made Available to Shareholders in Connection With Special Virtual-Only Meeting GlobeNewswire
Oct-02-20 05:05PM	Zomedica Announces Name Change GlobeNewswire
Sep-25-20 11:00AM	Zomedica Announces Shareholder Meeting Voting Results GlobeNewswire +5.50%
Sep-14-20 05:44PM	Zomedica Announces Letter to Shareholders in Connection With Annual and Special Virtual-Only Meeting GlobeNewswire
Sep-10-20 06:55AM	Zomedica Announces Presentation at Upcoming H.C. Wainwright Virtual Global Investment Conference GlobeNewswire
Sep-08-20 06:55AM	Zomedica to Develop Gastrointestinal Testing Panel for TRUFORMA GlobeNewswire
Aug-27-20 06:55AM	Zomedica Announces Letter From Robert Cohen, Interim CEO, Made Available to Shareholders in Connection With Annual and Special Virtual-Only Meeting GlobeNewswire
Aug-10-20 04:15PM	Zomedica Announces Second Quarter 2020 Financial Results GlobeNewswire
Aug-07-20 06:55AM	Zomedica Adds Two New Directors To Board Annual Meeting Materials Availability GlobeNewswire
Aug-03-20 06:55AM	Zomedica Announces Management Change GlobeNewswire
Jul-21-20 04:01PM	Successful Remote Installation of TRUFORMA GlobeNewswire
04:01PM	Successful Remote Installation of TRUFORMA GlobeNewswire
Jul-07-20 04:01PM	Zomedica Pharmaceuticals Corp. Closes $30 Million Public Offering GlobeNewswire
Jul-01-20 10:30PM	Zomedica Pharmaceuticals Corp. Announces $30 Million Public Offering GlobeNewswire -5.59%
04:04PM	Zomedica Pharmaceuticals Corp. Announces Proposed Public Offering GlobeNewswire
Jun-30-20 09:00AM	Zomedica (ZOM) in Focus: Stock Moves 7.2% Higher Zacks -9.20%
Jun-25-20 09:26AM	PCG Research Announces Publication of Update Report Covering Zomedica Pharmaceuticals Corp. Newsfile +22.11%
Jun-16-20 06:05PM	Zomedica Appoints New Interim CEO to Lead Organization Through Inaugural Product Launch GlobeNewswire
May-29-20 04:05PM	Zomedica Pharmaceuticals Corp. Closes $20 Million Public Offering GlobeNewswire
May-26-20 10:16PM	Zomedica Pharmaceuticals Corp. Announces $20 Million Public Offering GlobeNewswire
May-20-20 04:05PM	Zomedica Completes Verification of Three More Assays for its TRUFORMA Point-of-Care Diagnostic Platform GlobeNewswire
May-11-20 06:55PM	Zomedica Pharmaceuticals Corp (ZOM) Reports Q1 Loss, Lags Revenue Estimates Zacks
04:20PM	Zomedica Announces First Quarter 2020 Financial Results GlobeNewswire
Apr-21-20 06:55AM	Zomedica Completes Verification of its TRUFORMA Point-of-Care Diagnostic Platform and the First Assay, Canine total T4 GlobeNewswire
Apr-13-20 07:15PM	Zomedica Provides Corporate Update GlobeNewswire
Apr-07-20 11:32PM	Zomedica Pharmaceuticals Corp. Announces Pricing of $4.0 Million Public Offering GlobeNewswire
04:01PM	Zomedica Pharmaceuticals Corp. Announces Public Offering GlobeNewswire
Feb-26-20 05:25PM	Zomedica Pharmaceuticals Corp. Announces Year End 2019 Financial Results GlobeNewswire -18.76%
Feb-14-20 04:15PM	Zomedica Announces Completion of $2.5 Million Registered Direct Offering GlobeNewswire
Feb-12-20 08:43AM	Zomedica Announces $2.5 Million Registered Direct Offering GlobeNewswire -35.74%
Feb-11-20 06:55AM	Zomedica Files U.S. Patent Application for Fecal Parasite Detection GlobeNewswire +13.17%
Jan-30-20 06:55AM	Zomedica to Voluntarily Delist its Common Shares from TSX Venture Exchange Effective February 10, 2020 GlobeNewswire
Jan-23-20 06:55AM	Zomedica to Focus on TRUFORMA Commercialization GlobeNewswire
Jan-20-20 06:55AM	Zomedica Successfully Completes Development and Manufacturing Milestones for its Cancer Liquid Biopsy Platform GlobeNewswire
Dec-23-19 04:00PM	Hedge Funds Have Never Been This Bullish On Zomedica Pharmaceuticals Corp. (ZOM) Insider Monkey +5.26%
Dec-03-19 06:55AM	Zomedica Announces Management Changes GlobeNewswire
Nov-13-19 06:55AM	Zomedica Expands ZM-006 Pilot Efficacy Study GlobeNewswire
Nov-12-19 04:53PM	Zomedica Announces Third Quarter 2019 Financial Results GlobeNewswire
Nov-05-19 04:15PM	Zomedica Announces 2019 Annual Meeting Results GlobeNewswire
Oct-31-19 06:55AM	Zomedica Commences Final TRUFORMA Diagnostic Verification Study GlobeNewswire
Oct-03-19 11:27AM	CORRECTION FROM SOURCE: Zomedica Pushes TRUFORMA(TM) Closer To Commercialization, Targeting $2.7 Billion Companion Animal Diagnostics Market Newsfile
Oct-01-19 09:17AM	Zomedica Pushes TRUFORMA (TM) Closer To Commercialization, Targeting $2.7 Billion Companion Animal Diagnostics Market Newsfile -11.14%
Sep-18-19 01:39PM	Do Insiders Own Shares In Zomedica Pharmaceuticals Corp. (CVE:ZOM)? Simply Wall St.
Sep-17-19 06:55AM	Zomedica names Dr. Stephanie Morley President GlobeNewswire
Sep-11-19 09:09AM	PCG Research Announces Publication of Report Covering Zomedica Pharmaceuticals Corp. Newsfile +17.33%
09:00AM	Zomedica to Present at the Fall Investor Summit on Monday, September 16 in New York City ACCESSWIRE
Sep-03-19 06:55AM	Zomedica to Present at RHK Capital 2019 Disruptive Growth Conference, Fall Investor Summit, and Sidoti & Company Fall 2019 Investor Conference GlobeNewswire
Aug-19-19 06:55AM	Animal Health Veteran Johnny D. Powers Joins Zomedica Board of Directors GlobeNewswire
Aug-13-19 08:00AM	Zomedica Inc. Prepares to Launch Veterinarian Diagnostic Device, TRUFORMA(TM); Has Potential to Change Diagnostic Landscape in Animal Health (NYSE American: ZOM) ACCESSWIRE
Aug-08-19 04:08PM	Zomedica Announces Second Quarter 2019 Financial Results GlobeNewswire
Aug-07-19 06:55AM	Zomedica Announces TRUFORMA Assay Updates and R&D Expansion GlobeNewswire
Jul-25-19 06:55AM	Zomedicas Dr. Bonnie Bragdon to Speak at AVMA Convention 2019 on Sunday, August 4 GlobeNewswire
Jul-17-19 06:55AM	Zomedica Announces Initiation of a Digital Data Platform Enhancing its Diagnostic Pipeline GlobeNewswire
Jun-26-19 10:05AM	ZOM: One Instrument; Multiple Solutions Zacks Small Cap Research
Jun-13-19 06:55AM	Zomedica Announces Completion of Initial Development of a Lymphoma Assay for its Canine Cancer Liquid Biopsy Platform GlobeNewswire +10.20%
Jun-12-19 04:35PM	Zomedica to Present at Raymond James Life Sciences and MedTech Conference GlobeNewswire -13.05%
Jun-10-19 06:00AM	Zomedica Announces $7 Million Second Tranche Closing of Preferred Shares GlobeNewswire +6.57%
May-21-19 06:55AM	Zomedica Announces Achievement of Product Development Milestones on its TRUFORMA Point-of-Care Diagnostic Platform GlobeNewswire +12.96%
May-10-19 05:21PM	Zomedica Announces First Quarter 2019 Financial Results GlobeNewswire +6.69%
06:00AM	Zomedica Announces Private Placement of Preferred Shares GlobeNewswire
Mar-26-19 06:00AM	Zomedica Pharmaceuticals Corp. Announces Pricing of $3 Million Underwritten Public Offering of Common Shares GlobeNewswire -43.82%
Mar-25-19 04:01PM	Zomedica Pharmaceuticals Corp. Announces Proposed Public Offering of Common Shares GlobeNewswire -12.38%
Mar-05-19 06:55AM	Zomedica Initiates ZM-006 Pilot Efficacy Study and Provides Corporate Updates GlobeNewswire +6.77%
Feb-26-19 04:05PM	Zomedica Pharmaceuticals Corp. Announces Year End 2018 Financial Results GlobeNewswire
Jan-15-19 06:55AM	Zomedica Appoints Dr. Bonnie Bragdon as Vice President of Veterinary Affairs GlobeNewswire +5.36%
Jan-14-19 06:55AM	Zomedica Announces $4.28 Million Private Placement Closing and Corporate Update GlobeNewswire -7.44%
Dec-20-18 05:23PM	Zomedica Provides Update on Pipeline Development and Announces At-The-Market Offering Program GlobeNewswire +9.32%
Dec-19-18 06:00AM	IncellDx and Zomedica Sign Diagnostic CTC Assay Development Agreement for Canine Cancer PR Newswire -13.87%
Nov-28-18 09:53AM	Qorvo, Zomedica Tie-Up to Enhance Vet Health with BAW Sensors Zacks +12.34%
Nov-27-18 06:51AM	Zomedica Signs Exclusive Agreement with Qorvo Biotechnologies for Global Veterinary Rights to Diagnostic Point-of-Care Platform GlobeNewswire -10.47%
06:50AM	Zomedica Announces $10 Million Private Offering of Common Shares GlobeNewswire
Nov-26-18 07:25AM	Analysis: Positioning to Benefit within Dominion Energy Midstream Partners, LP, Blue Capital Reinsurance, CRH Medical, Friedman Industries, CM Finance, and Zomedica Pharmaceuticals Research Highlights Growth, Revenue, and Consolidated Results GlobeNewswire +11.69%
Nov-13-18 04:47PM	Zomedica Pharmaceuticals Corp. Announces Third Quarter 2018 Financial Results GlobeNewswire -5.17%
Nov-12-18 04:30PM	Zomedica Pharmaceuticals Corp. to Present at Jefferies 2018 London Healthcare Conference and LD Micro Main Event XI GlobeNewswire
Oct-16-18 09:00AM	SeeThruEquity Issues Update on Zomedica Pharmaceuticals Corp. ACCESSWIRE
Sep-18-18 06:55AM	Zomedica Pharmaceuticals Corp. to Present at LD Micro NYC Summit and Cantor 2018 Global Healthcare Conference GlobeNewswire
Aug-15-18 04:15PM	Zomedica Announces 2018 Annual Meeting Results GlobeNewswire
Aug-09-18 04:01PM	Zomedica Pharmaceuticals Corp. Announces Second Quarter 2018 Financial Results GlobeNewswire
Jun-28-18 08:57PM	Zomedica Announces Interim Closing and Extension of Its Private Offering of Common Shares GlobeNewswire
Jun-25-18 05:59PM	Zomedica Joins Russell 3000 and Russell Microcap® Indexes GlobeNewswire -15.77%
Jun-19-18 06:54AM	Zomedica Provides Product Development Update GlobeNewswire
Jun-14-18 06:15PM	Zomedica Announces Changes to Commercialization Leadership Team GlobeNewswire
May-15-18 04:06PM	Zomedica Pharmaceuticals Corp. Announces First Quarter 2018 Financial Results GlobeNewswire
04:01PM	Zomedica Announces Up to $10 Million Private Offering of Common Shares GlobeNewswire
May-14-18 07:30AM	Wired News Zomedica Inks Deal with Seraph to Develop and Market Seraphs Novel Pathogen Detection System for Veterinarians ACCESSWIRE -5.00%
May-10-18 06:55AM	Zomedica Signs Agreement With Seraph Biosciences for Innovative Veterinary Point-of-Care Diagnostic GlobeNewswire
May-07-18 06:55AM	Zomedica to Present at 2018 Disruptive Growth & Healthcare Conference GlobeNewswire
Mar-26-18 09:00AM	SeeThruEquity Issues Update on Zomedica Pharmaceuticals Corp. (NYSE American: ZOM) ACCESSWIRE
Mar-07-18 06:55AM	Zomedica to Present at 30th Annual ROTH Conference GlobeNewswire
Feb-28-18 04:11PM	Zomedica Pharmaceuticals Corp. Announces Year End 2017 Financial Results GlobeNewswire

Zomedica Corp., a development stage veterinary diagnostic and pharmaceutical company, engages in the discovery, development, and commercialization of pharmaceuticals for the companion pet. Its lead drug product candidate is ZM-007, an oral suspension formulation of metronidazole for the treatment of acute diarrhea in small dog breeds and puppies. The company is also developing ZM-012, a tablet formulation of metronidazole targeting the treatment of acute diarrhea in dogs; ZM-006, a transdermal gel formulation of methimazole targeting hyperthyroidism in cats; and ZM-011, a transdermal gel formulation of fluoxetine for the treatment of feline behavioral disorders, such as inappropriate urination. It has a collaboration agreement with Celsee, Inc. for the development and commercialization of liquid biopsy assays and related consumables for the detection of cancer in companion animals; and with Seraph Biosciences, Inc. for development and commercialization of novel pathogen detection system. The company was formerly known as Zomedica Pharmaceuticals Corp. and changed its name to Zomedica Corp. in October 2020. Zomedica Corp. was founded in 2015 and is headquartered in Ann Arbor, Michigan.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
POWERS JOHNNY D	Director	Jul 07	Buy	0.16	625,000	100,000	625,000	Jul 07 04:53 PM

open in yahoo | open in reuters | open in google

Upgrade your FINVIZ experience